FERMENTALG (EPA:FALG)

PRESS RELEASE

published on 10/07/2025 at 18:00, 7 months 1 day ago

Revenue at the end of September 2025: EUR9.6 million // Confirmation of a double-digit growth target in 2025 and significant catalysts for 2026
Fermentalg announces stable invoicing in September 2025, aiming for €13 million annual revenue with new products and expansion. Focus on infant nutrition, aquaculture, and natural blue dye

Revenue Aquaculture FERMENTALG Natural Blue Dye Infant Nutrition
BRIEF

published on 09/12/2025 at 15:05, 7 months 27 days ago

Fermentalg: Videoconferencing for Individual Investors

Investors Sustainable Development FERMENTALG Videoconference Listed On Euronext
BRIEF

published on 09/11/2025 at 18:05, 7 months 27 days ago

Fermentalg: 2025 Half-Year Results and Expansion Strategy

Half-year Results FERMENTALG Geographic Expansion BioSolutions Blue Food Coloring
PRESS RELEASE

published on 09/11/2025 at 18:00, 7 months 27 days ago

2025 half-year results: Strategic enhancement of the offering and stable operating income in a complex and uncertain economic environment
Fermentalg presents its 2025 half-year results showing revenue growth and stable operating income. Expansion in BioSolutions portfolio and markets, strategic agreements, and FDA approval highlighted

Revenue Growth FDA Approval FERMENTALG 2025 Half-Year Results BioSolutions
BRIEF

published on 09/08/2025 at 15:05, 8 months 1 day ago

Fermentalg is organizing a video conference for investors on September 15, 2025

Financial Results Investors Development FERMENTALG Videoconferencing
BRIEF

published on 09/08/2025 at 12:05, 8 months 1 day ago

Fermentalg: Update on Voting Rights and Shares

Share Capital Voting Rights AMF Transparency FERMENTALG
BRIEF

published on 08/05/2025 at 18:05, 9 months 3 days ago

Fermentalg: Update of voting rights as of July 31, 2025

Voting Rights Actions Investment AMF Regulations FERMENTALG
BRIEF

published on 07/21/2025 at 18:05, 9 months 18 days ago

Half-yearly report on Fermentalg's liquidity contract

Liquidity Contract Financial Transactions Gilbert Dupont FERMENTALG Aquatic Microorganisms
BRIEF

published on 07/08/2025 at 18:05, 10 months ago

Fermentalg Records 20% Half-Year Growth

Convertible Bonds Food Sovereignty Sales Growth Ωrigins™ Range Natural Coloring Galdieria Blue
PRESS RELEASE

published on 07/08/2025 at 18:00, 10 months ago

Fermentalg continues on its path of development trajectory with sales of 7.6M EUR for the 1st half of 2025
Fermentalg reports 20% sales growth in 1st half of 2025 with €7.6 million revenue, driven by Ωrigins™ range. Expansion into pet food, infant nutrition, aquaculture. Approval of Galdieria Blue as natural food colorant by FDA. Target sales of €25 million by 2026. Full repayment of convertible bonds

Convertible Bonds Sales Growth FERMENTALG Ωrigins™ Galdieria Blue

Published on 05/09/2026 at 01:55, 13 hours 31 minutes ago

Prospect Ridge Announces Board Resignation
Published on 05/09/2026 at 01:40, 13 hours 46 minutes ago

Findev Inc. Issues Corrective Disclosure
Published on 05/09/2026 at 01:30, 13 hours 56 minutes ago

Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 15 hours 26 minutes ago

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:01, 16 hours 25 minutes ago

Water Ways Announces Corporate Updates

View all ACCESSWIRE

Published on 05/08/2026 at 20:38, 18 hours 48 minutes ago

EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 20 hours 13 minutes ago

EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 20 hours 24 minutes ago

Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/08/2026 at 18:29, 20 hours 57 minutes ago

Designated Person Notification
Published on 05/08/2026 at 18:21, 21 hours 5 minutes ago

Bond Issue

View all EQS

Published on 05/07/2026 at 19:15, 1 day 20 hours ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:06, 1 day 20 hours ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 18:17, 1 day 21 hours ago

DESCRIPTION OF THE LOUIS HACHETTE GROUP SHARE BUYBACK PROGRAM 2026-2027
Published on 05/07/2026 at 18:12, 1 day 21 hours ago

LNA SANTE : Q1 2026
Published on 05/07/2026 at 17:45, 1 day 21 hours ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE

News